Results 71 to 80 of about 13,123 (252)

Cytoreductive HIPEC-Combined Surgery in Treatment of Advanced Ovarian Cancer

Креативная хирургия и онкология, 2022
Background. Ovarian cancer ranks 5th in the structure of female oncological mortality in the Russian Federation, with a first-year post-diagnosis rate of almost 35%. In 75% cases, ovarian cancer is diagnosed at stages III—IV.
M. V. Zabelin, A. S. Safonov, N. V. Kuznetsov   +2 more
doaj   +1 more source

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6)

BMC Cancer, 2019
Upfront cytoreductive surgery with HIPEC (CRS-HIPEC) is the standard treatment for isolated resectable colorectal peritoneal metastases (PM) in the Netherlands.
K. Rovers, C. Bakkers, G. Simkens, J. Burger, S. Nienhuijs, G. Creemers, A. M. Thijs, A. Brandt-Kerkhof, E. Madsen, N. Ayez, N. L. de Boer, E. van Meerten, J. Tuynman, M. Kusters, N. Sluiter, H. Verheul, H. J. van der Vliet, M. Wiezer, D. Boerma, E. Wassenaar, M. Los, C. B. Hunting, A. Aalbers, N. Kok, K. Kuhlmann, H. Boot, M. Chalabi, S. Kruijff, L. Been, R. V. van Ginkel, D. D. de Groot, R. Fehrmann, J. D. de Wilt, A. Bremers, P. D. de Reuver, S. Radema, K. Herbschleb, W. V. van Grevenstein, A. Witkamp, M. Koopman, N. Haj Mohammad, E. V. van Duyn, W. Mastboom, L. Mekenkamp, J. Nederend, M. Lahaye, P. Snaebjornsson, C. Verhoef, H. V. van Laarhoven, A. Zwinderman, J. Bouma, O. Kranenburg, I. van ’t Erve, R. Fijneman, M. Dijkgraaf, P. Hemmer, C. Punt, P. Tanis, I. D. de Hingh   +58 more
semanticscholar   +1 more source

Sensitivity of Platinum‐Based Chemotherapy and Efficacy of Arsenic Trioxide‐Based Non‐Platinum Chemotherapy Following the Progression of PARPi Maintenance Therapy: A Real‐World Study

Cancer Medicine, Volume 14, Issue 18, September 2025.
ABSTRACT Background Cross‐resistance is observed between platinum and Poly (ADP‐ribose) polymerase inhibitors (PARPi). We aim to propose the definition of PARPi resistance and demonstrate the best therapeutic strategy for patients with PARPi resistance.
Rui Gou, Qi Xie, Haishan Ren, Hui Zhang, Tingting Wang, Ziyu Li, Zhenning Li, Ruichen Wang, Yingchao Yang, Xiaoyan Shen, Yi Li, Yue Wang, Lihui Wei, Xiaoping Li   +13 more
wiley   +1 more source

Laparoscopic Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal Surface Malignancies (PSM): Italian PSM Oncoteam Evidence and Literature Review [PDF]

, 2022
Antonio Sommariva, Mario Valle, Roberta Gelmini, Marco Tonello, Fabio Carboni, Giovanni De Manzoni, Lorena Sorrentino, Enrico Maria Pasqual, Stefano Bacchetti, C. Sassaroli, Andrea Di Giorgio, Massimo Framarini, Daniele Marrelli, Francesco Casella, Orietta Federici   +14 more
openalex   +1 more source

Atypical Presentation of Metastasis of Appendiceal Cancer: Neoplastic Growth Infiltrating an Inguinal Hernia

Clinical Case Reports, Volume 13, Issue 9, September 2025.
ABSTRACT Although rare, appendiceal cancer can metastasize to unusual sites, including the inguinal canal. In patients with a history of abdominal malignancy presenting with an inguinal hernia, metastatic disease should be considered for adequate recognition and early oncologic intervention.
Peter Mounas, Tony Elias, Amit Kharod, Nikolette Zamarra   +3 more
wiley   +1 more source

Hyperthermic intraperitoneal chemotherapy: Ideal and reality

Asian Journal of Surgery
Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) is a new adjuvant therapy for the treatment of abdominal malignant tumors and metastases, which has shown great potential.
Fan-He Dong, Yu-Qiang Shan, Wen-Cheng Kong, Hao-Ran Wei, Lin-Po Zhou, Ye-Bin Yang, Jing Shi, Cheng-Hao Ji, Yi-Jia Zhang   +8 more
doaj   +1 more source

Meta‐analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy

BJS Open, 2019
Background Up to 15 per cent of colorectal cancers present with peritoneal metastases (CPM). Cytoreductive surgery and heated intraperitoneal chemotherapy (CRS + HIPEC) aims to achieve macroscopic tumour resection combined with HIPEC to destroy ...
S. Hallam, R. Tyler, M. Price, A. Beggs, H. Youssef   +4 more
doaj   +1 more source

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin in pediatric patients with peritoneal mesothelioma: a single institution experience and long term follow up [PDF]

, 2021
Parisa Malekzadeh, Meghan L. Good, Marybeth S. Hughes   +2 more
openalex   +1 more source

Hypertherme intraperitoneale chemotherapie (HIPEC)

Huisarts en wetenschap, 2013
Hemmer PHJ, Van Leeuwen BL. Hyperthermic intraperitoneal chemotherapy (HIPEC). Huisarts Wet 2013;56(1):36-9.Surgery forms the basis of cancer therapy, and surgical resection sometimes improves survival in metastatic disease. One such surgical approach is cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).
Hemmer, Patrick, Van Leeuwen, Barbara
openaire   +2 more sources

Worldwide barriers of optimal surgical care provision in advanced ovarian cancer

International Journal of Gynecology &Obstetrics, Volume 171, Issue S1, Page 129-137, September 2025.
Abstract Ovarian cancer (OC) remains one of the most challenging gynecological malignancies to cure, despite recent advances in treatment. Disparities in the diagnosis, management, and survival of OC exist worldwide and addressing them remains an ongoing challenge.
Shriya Varghese, Myong Cheol Lim, Robert Armbrust, Rene Pareja, Christina Fotopoulou   +4 more
wiley   +1 more source